Midazolam Suppresses Hepatocellular Carcinoma Cell Metastasis and Enhances Apoptosis by Elevating miR-217

BACKGROUND: Hepatocellular carcinoma (HCC) is a significant cause of human death in the world. Recently, it is found that midazolam can modulate miRs to participate in HCC progression. This research project was designed to elucidate the impacts of midazolam and miR-217 on HCC cell metastasis and apo...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Qian, Xia, Yanqiong, Yang, Leilei, Wang, Bo, Peng, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926537/
https://www.ncbi.nlm.nih.gov/pubmed/35309842
http://dx.doi.org/10.1155/2022/2813521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8926537/
https://www.ncbi.nlm.nih.gov/pubmed/35309842
http://dx.doi.org/10.1155/2022/2813521

Ejemplares similares